REDWOOD SHORES, Calif., June 18,
2020 /PRNewswire/ -- Electronic Data Capture (EDC) is no
longer sufficient for today's clinical trials, which are
incorporating more virtual components and becoming more
decentralized. While traditional EDC systems capture data from
forms, patient data in clinical trials is now flowing at a rapid
pace and at a high volume from a myriad of novel sources, such as
wearables. To address this challenge, Oracle Health Sciences, an
early pioneer in eClinical technology, has introduced Clinical One
Data Collection Cloud Service. With the ability to capture data
from any source into a single, unified platform, Oracle Clinical
One is redefining how technology supports clinical research to
improve efficiency and help speed the delivery of breakthrough
therapies.
"The Oracle Clinical One platform is a game-changer," said
Michele Taylor-Scott, head of data
management at Health Decisions. "We have used Clinical One for
stand-alone randomization and trial supply management and are
excited to now be able to use it for data collection. Clinical One
is very user-friendly and we feel it will enable us to reduce not
only database build timelines, but also database lock timelines,
which are both critical in clinical trials. I say that with
confidence because with Clinical One, we have the ability to build
a full study in a matter of weeks, instead of months, and mid-study
changes or post-production changes can be done in real-time without
a lengthy migration process."
Current eClinical technology has not kept pace with the
acceleration of science and clinical research which drives up trial
costs. According to Gartner's 2020 Industry Vision report, "the
current rate of trial cost increase is unsustainable, and clinical
leaders must challenge the existing model and enable new approaches
to take hold."1
Oracle Clinical One Data Collection collects data from any
source – forms, wearable sensors, patient apps, electronic health
records (EHR), labs – and harmonizes it in a single place. This
expanded data gives sites and study teams a more complete picture
of the patient's experience, and ultimately, the safety and
efficacy of the investigative therapy, allowing them to make better
decisions. And, because Clinical One is a unified
platform, sites can randomize, dispense drug, and collect
patient data in one system.
"Using Oracle Clinical One will have a positive impact on our
data collection and randomization processes for current and future
clinical trials as we help bring new women's health therapies to
market," added Taylor-Scott.
Because it is easily configurable, Clinical One Data Collection
meets the needs of all trial types—from the simplest Phase I and
Post-Market studies to the most complex Phase III studies, across
all therapeutic areas. For example, Clinical One is already being
used across the industry for many trials including those focused on
COVID-19 treatments and vaccines.
"The industry has been asking for technology that supports a new
way to approach clinical trials that is simpler, easier, and lower
cost, but also accommodates the evolving needs of decentralized
trials. To meet this need, we, as an industry, must think and act
differently," said Steve Rosenberg,
senior vice president and general manager, Oracle Health Sciences.
"Our goal is to deliver on this promise by providing the industry
with a unified platform that supports today's needs as well as
tomorrow's requirements. Clinical One Data Collection supports
event-based data collection and streamlines workflow, providing our
customers with the agility and cost-savings they need to get
therapies to market faster."
To learn more about Oracle Health Sciences Clinical One Data
Collection and to see the capability in action, please join the
live webinar on June 23, 2020 at
11:00am ET – register here.
Recently, Oracle also announced its Clinical One Randomization
and Supplies Management Cloud Service, which reduces the time
required for study set up from nearly two months to just a few
days. For more information about Clinical One:
https://www.oracle.com/clinical-one
- Gartner, Industry Vision: Life Science CIOs Must Transform
Clinical Development With Digital Trials Refreshed 15 January 2020, Published 21 August 2018
About Oracle Health Sciences
As a leader in Life
Sciences cloud technology, Oracle Health Sciences' Clinical One and
Safety One are trusted globally by professionals in both large and
emerging companies engaged in clinical research and
pharmacovigilance. With over 20 years' experience, Oracle Health
Sciences is committed to supporting clinical development,
delivering innovation to accelerate advancements, and empowering
the Life Sciences industry to improve patient outcomes. Oracle
Health Sciences. For life.
About Oracle
The Oracle Cloud offers a complete suite
of integrated applications for Sales, Service, Marketing, Human
Resources, Finance, Supply Chain and Manufacturing, plus Highly
Automated and Secure Oracle Cloud Infrastructure featuring the
Oracle Autonomous Database. For more information about Oracle
(NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle and Java are registered trademarks
of Oracle and/or its affiliates. Other names may be trademarks of
their respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/oracle-unveils-clinical-one-data-collection-cloud-service-301079188.html
SOURCE Oracle Corporation